Hubert G. M. Leufkens - Publications, H-index & Citations

Hubert G. M. Leufkens

utrecht institute of pharmaceutical science

72H指数

509论文数

2.0W被引数

收录论文 238

发表时间

European Science for Health Research Needs and Priorities 欧洲科学：健康研究需求与优先事项

European Journal of Pharmaceutical Sciences

IF4.7

2026-05-30

OAAI

Mareike Lutz; Tessa Moleman; Hubert G.M. Leufkens

Challenges and opportunities of adding CFTR modulators for cystic fibrosis to the WHO essential medicines list 将CFTR调节剂纳入世界卫生组织基本药物清单的挑战与机遇

Journal of Cystic Fibrosis

IF6

2025-07-05

OAAI

Enrico Costa; Hendrika A van den Ham; Hubert G.M. Leufkens

Implementation of indication restrictions made by European regulatory action for antibiotics - amoxicillin 实施欧洲监管行动对阿莫西林抗生素提出的指示性限制

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2025-06-01

OAAI

Opalska, Aleksandra; Kwa, Marcel; Leufkens, Hubert

Medicines not recommended for inclusion in the who essential medicines list: a retrospective observational study 不推荐列入世卫组织基本药物清单的药物: 一项回顾性观察性研究

FRONTIERS IN MEDICINE

IF3

2025-03-17

OAAI

Costa, Enrico; Del Grosso, Vittorio; Cappello, Bernadette; Genazzani, Armando A.; Huttner, Benedikt; Leufkens, Hubert G. M.; Magrini, Nicola; Nonino, Francesco; Wirtz, Veronika J.; van den Ham, Hendrika A.; Moja, Lorenzo

Differential times of submission and approval of CFTR modulators for the treatment of Cystic Fibrosis in the United States and the European Union

JOURNAL OF CYSTIC FIBROSIS

IF6

2025-01-01

OAAI

Costa, Enrico; Girotti, Silvia; Mathieu, Clement; Castellani, Carlo; Ross, Joseph S.; Taylor-Cousar, Jennifer L.; Leufkens, Hubert G. M.

Globalization in clinical drug development for sickle cell disease 镰状细胞病临床药物开发的全球化

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2024-11-12

OAAI

Costa, Enrico; Ware, Russell E.; Tshilolo, Leon; Makani, Julie; Leufkens, Hubert G. M.; Luzzatto, Lucio

Feasibility of disease terminology systems for mapping orphan conditions and therapeutic indications of designated orphan medicines in the European Union

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2024-11-01

OAAI

Jadoenathmisier, Keerti; Stoyanova-Beninska, Violeta; Soons, Inge M.; Leufkens, Hubert G. M.; Bloem, Lourens; Pasmooij, Anna M. G.

Identifying Medicine Shortages With the Twitter Social Network: Retrospective Observational Study 通过Twitter社交网络识别药物短缺: 回顾性观察研究

JOURNAL OF MEDICAL INTERNET RESEARCH

IF6

2024-08-06

OAAI

Postma, Doerine J.; Heijkoop, Magali L. A.; De Smet, Peter A. G. M.; Notenboom, Kim; Leufkens, Hubert G. M.; Mantel-Teeuwisse, Aukje K.

Successes and pitfalls in orphan drug development for sickle cell disease 镰状细胞病孤儿药物开发的成功和陷阱

BLOOD ADVANCES

IF7.1

2024-05-20

OAAI

Costa, Enrico; Isgro, Antonella; de Montalembert, Mariane; Leufkens, Hubert G. M.; Ware, Russell E.; De Franceschi, Lucia

The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report 荷兰药品监管科学的演变: 不仅仅是一份国家报告

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2024-04-28

OAAI

Pasmooij, Anna M. G.; Mol, Peter G. M.; Bot, Jacob Cornelis; Leufkens, Hubert G. M.

Medicine shortages: impact behind numbers

JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE

IF2.5

2024-03-11

OAAI

Postma, Doerine J.; Notenboom, Kim; De Smet, Peter A. G. M.; Leufkens, Hubert G. M.; Mantel-Teeuwisse, Aukje K.

Trends in orphan medicinal products approvals in the European Union between 2010-2022 2010至2022间欧盟孤儿药品批准的趋势

ORPHANET JOURNAL OF RARE DISEASES

IF3.5

2024-02-27

OAAI

Bouwman, Luisa; Sepodes, Bruno; Leufkens, Hubert; Torre, Carla

Uptake of orphan drugs in the WHO essential medicines lists

BULLETIN OF THE WORLD HEALTH ORGANIZATION

IF5.7

2024-01-01

OAAI

Costa, Enrico; Moja, Lorenzo; Wirtz, Veronika J.; van den Ham, Hendrika A.; Huttner, Benedikt; Magrini, Nicola; Leufkens, Hubert G. M.

Post-approval quality-related regulatory actions for biopharmaceuticals approved in the European Union and the United States between 1995 and 2019 欧盟和美国1995年和2019批准的生物药品批准后质量相关监管行动

DRUG DISCOVERY TODAY

IF7.5

2023-10-01

OAAI

Alsamil, Ali M.; Gardarsdottir, Helga; Leufkens, Hubert G.; Egberts, Toine C.; Giezen, Thijs J.

Traits, trends and hits of orphan drug designations in cystic fibrosis 囊性纤维化孤儿药物命名的特征，趋势和命中

JOURNAL OF CYSTIC FIBROSIS

IF6

2023-09-01

OAAI

Costa, Enrico; Girotti, Silvia; van den Ham, Hendrika A.; Cipolli, Marco; van der Ent, Cornelis K.; Taylor-Cousar, Jennifer L.; Leufkens, Hubert G. M.

Pharmaceutical Scientists' Perspectives on Capacity Building in Pharmaceutical Sciences

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2023-07-01

OAAI

Kusynova, Z.; van den Ham, H. A.; Leufkens, H. G. M.; Mantel-Teeuwisse, A. K.

Longitudinal study of Good Pharmacy Practice roles covered at the annual world pharmacy congresses 2003-2019

JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE

IF2.5

2022-11-28

OAAI

Kusynova, Zuzana; van den Ham, Hendrika A.; Leufkens, Hubert G. M.; Mantel-Teeuwisse, Aukje K.

Emergent treatments for β-thalassemia and orphan drug legislations Β-地中海贫血的紧急治疗和孤儿药立法

DRUG DISCOVERY TODAY

IF7.5

2022-11-01

OAAI

Enrico, Costa; Maria, Domenica Cappellini; Stefano, Rivella; Adriana, Chilin; Eva, Alessi; Massimo, Riccaboni; Hubert, G. M. Leufkens; Luzzatto, Lucio

Nature and timing of post-approval manufacturing changes of tumour necrosis factor α inhibitor products: A 20-year follow-up study of originators and biosimilars

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2022-08-01

OAAI

Alsamil, Ali M.; Giezen, Thijs J.; Egberts, Toine C.; Doevendans, Erik; Leufkens, Hubert G.; Gardarsdottir, Helga

Four scenarios for the future of medicines and social policy in 2030

DRUG DISCOVERY TODAY

IF7.5

2022-08-01

OAAI

Leufkens, Hubert G.; Kusynova, Zuzana; Aitken, Murray; Hoekman, Jarno; Stolk, Pieter; Klein, Kevin; Mantel-Teeuwisse, Aukje K.

研究方向